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We studied 138 glycopeptide-resistant enterococci (GRE) strains, consisting of 131 glycopeptide-resistant Enterococcus faecium
(GREfm) and 7 glycopeptide-resistant Enterococcus faecalis (GREfs). The GREfm strains were resistant to penicillin, ampicillin,
vancomycin, and teicoplanin, while the GREfs strains were only resistant to vancomycin and teicoplanin. The van A gene was the
only glycopeptide determinant present in all GRE isolates investigated. Genes coding for Hyl and Hyl+ Esp were detected in 39
(29.8%) and 92 (70.2%) of the 131 GREfm isolates, respectively. Three of the 7 GREfs were positive for gelE+asa 1 genes, 3 for gel E
gene, and 1 for asa 1 gene. The genetic relationship between the 138 GRE was analyzed by pulsed-ﬁeld gel electrophoresis (PFGE)
and multilocus sequence typing (MLST). GREfm isolates were clustered in a single genogroup (pulsotype A), and GREfs were
clustered in six genogroups (pulsotypes B-G). Among the isolates investigated by MLST, only 18 PCR products were sequenced
(12 E. faecium and 6 E. faecalis), and 9 sequence types (STs) were identiﬁed.
1.Introduction
Enterococci form part of the normal ﬂora of both the
human and animal gastrointestinal tract but are also found
inotheranatomicalsitesincludingthevaginaandoralcavity.
Of the 20 enterococcal species known, Enterococcus faecalis
and Enterococcus faecium are among the leading causes of
several human infections, including bacteremia, septicemia,
endocarditis, urinary tract infections, wound infections,
neonatal sepsis, and meningitidis.
Glycopeptide-resistant enterococci (GRE) are a mutant
of Enterococcus that originally developed in individuals
exposed to antibiotics. They have increasingly emerged as
a major cause of nosocomial infections worldwide [1].
This emergence has been associated with gradual replace-
ment of Enterococcus faecalis by Enterococcus faecium and
an epidemic rise of vancomycin-resistant E. faecium [2].
Vancomycin is the antibiotic of choice for infections caused
by penicillin-resistant strains, alone or in combination with
aminoglycosides. Acquired vancomycin resistance to this
organism greatly reduces the number of treatment options
and, therefore, constitutes a major therapeutic concern. This
problem is further compounded by the fact that resistance
genes can potentially be transferred to other pathogenic
organisms such as Staphylococcus aureus.
GREstrainswerereportedfortheﬁrsttimeinFranceand
the United Kingdom in 1988 [3], and then in the USA [4]. In
France, the incidence of glycopeptide resistance in E. faecium
bacteremia is less than 5% [3], the proportion of GRE is less
than2%,andtheprevalenceratehasremainedat0.01%[5, 6].
The main risk factor for the development of GRE
strains is the excessive use of glycopeptides, but the use
of third-generation cephalosporins and ﬂuoroquinolones is
also involved in the selection of GRE [7].2 International Journal of Microbiology
T h r e eg l y c o p e p t i d er e s i s t a n c ep h e n o t y p e sh a v eb e e n
distinguished in the GRE strains on the basis of the level
and inducibility of resistance to vancomycin and teicoplanin
[8]. The Van A type is characterized by acquired inducible
resistance to both vancomycin and teicoplanin [9]. Strains of
the Van B type have acquired inducible resistance to various
levelsofvancomycinbutnottoteicoplanin[10].Constitutive
low-level resistance to vancomycin (Van C1, Van C2/3, Van
E, and Van G phenotypes) is an intrinsic property of motile
enterococci, E. gallinarum, E. casseliﬂavus,a n dE. ﬂavescens
[11, 12]. van A and van B are the main resistance genotypes
reported for E. faecalis and E. faecium, the two species
mostfrequentlyisolatedfromclinicalsites.Numerousfactors
are associated with a greater risk of acquiring enterococcal
infections. These factors, including antimicrobial resistance
and expression of virulence factorsassociated with infection-
derived E. faecalis and E. faecium strains, possess several
putative virulence determinants, including aggregation sub-
stance, gelatinase, cytolysin, enterococcal surface protein,
and hyaluronidase [13]. The ﬁrst four virulence factors are
found in E. faecalis, while the fourth and ﬁfth virulence
factors are speciﬁc for E. faecium [13].
Aggregation substance, encoded by asa1,whichiscarried
on a plasmid, is a pheromone-inducible protein that enables
the conjugative transfer of sex pheromone gene-containing
plasmids through the clumping of one Enterococcus to
another [14]. As a virulence factor, aggregation substance
increases bacterial adherence to renal tubular cells [15]a n d
heart endocardial cells [16].
Gelatinase, encoded by the chromosomal gelE,i sa ne x t r a
cellularzincendopeptidasethathydrolyzescollagen,gelatine,
and small peptides [17].
The production of cytolysin has also been shown
to signiﬁcantly worsen the severity of endocarditis [18].
Cytolysin genes are carried on a plasmid or are integrated
into the bacterial chromosome [19]. Cytolysin consists of
two components, lysine (L) and activator (A). The cytolysin
operon consists of ﬁve genes, of which cyl L1, cyl L2, cyl
M, and cyl B are relevant to the expression of component L,
whereas cyl A is necessary for the expression of component
A.
The enterococcal surface protein, encoded by the chro-
mosomal gene esp, has an interesting structure that includes
a central core consisting of distinct tandem repeat units.
Enterococcal surface protein is associated with increased
virulence [20], colonization and persistence in the urinary
tract, and bioﬁlm formation [21].
Another virulence factor, hyaluronidase, was described
in E. faecium [22]. The E. faecium hyaluronidase, encoded
by the chromosomal gene hyl, shows homology to the
hyaluronidases previously described in Streptococcus pyo-
genes, Staphylococcus aureus,a n dStreptococcus pneumoniae
which are believed to contribute to invasion of the nasophar-
ynx and pneumococcal pneumonia [23].
The aim of this study was to use pulsed-ﬁeld gel elec-
trophoresis (PFGE) and multilocus sequence typing (MLST)
to characterize glycopeptide-resistant E. faecium (GREfm)
and glycopeptide-resistant E. faecalis (GREfs) isolates from
clinical specimens obtained from patients admitted to
Picardy hospitals (France). The van genotypes of the GRE
isolates were determined, and the virulence factor genes were
detected.
2.MaterialsandMethods
2.1. Setting. One hundred thirty-eight GRE clinical isolates
obtained from 127 patients were collected from ﬁve hospitals
in the Picardy region (Amiens University Hospital (AUH;
128 isolates), Picardy Private Hospital (PPH; 6 isolates),
Montdidier hospital (MH; 2 isolates), Doullens Hospital
(DH;1isolate),andSaintQuentinHospital(SQH;1isolate))
between April 2004 and January 2009. Clinical isolates were
recovered from rectal swabs (n = 103), from urine (n = 12),
from pus (n = 6), from peritoneal ﬂuid (n = 4), from blood
(n = 3), from drainage tube (n = 2), from bile (n = 2),
from urethral swab (n = 1 ) ,f r o mv a g i n a ls w a b( n = 1),
fromabscess(n = 1),fromcatheter(n = 1),frompyosalpinx
(n = 1), and from sputum (n = 1) (Table 1).
ThemedicalrecordsofallpatientswithGREisolateswere
reviewedretrospectively.Clinicaldatacollectedincludedage,
gender, the hospital and the ward in which these patients
were hospitalized and where they came.
2.2. Deﬁning Samples. In this study, the clinical samples are
the samples taken for diagnosis, and the rectal swabs are the
samples taken for screening.
2.3. Culture and Phenotypic Identiﬁcation. Rectal swabs were
cultured on Enterococcosel selective agar supplemented
with 8μg/mL vancomycin (Becton Dickinson, France) with
teicoplanindisc.ClinicalsampleswereculturedonColumbia
agar supplemented with 5% deﬁbrinated horse blood, and
both were incubated aerobically for 24–48 hours at 37
◦C.
Isolates were identiﬁed as E. faecium or E. faecalis by
rapid ID32 Strep system according to the manufacturer’s
instructions (BioM´ erieux, France).
2.4. Antimicrobial Susceptibility Testing. Resistance to van-
comycin, teicoplanin, penicillin, and ampicillin and to
kanamycin, gentamicin, and streptomycin was tested by
disc diﬀusion methods according to the Comit´ ed e
l’Antibiogramme de la Soci´ et´ eF r a n c ¸aise de Microbiologie (CA-
SFM) guidelines [24]. Minimum inhibitory concentrations
(MICs) of these antimicrobial agents were determined using
E-test strips (BioM´ erieux, France), and the results were
interpreted according to established breakpoint values [24].
E. faecium Van A CIP 104676 and E. faecalis Van B CIP
104105 standard strains were used as reference strains.
2.5. Identiﬁcation of GRE and Glycopeptide Resistance Deter-
minants. TotalDNAwasextractedfromenterococcibyusing
the BioRobot EZ1 extractor apparatus (QIAGEN, France)
according to the manufacturer’s recommendations. In order
todeterminethegenotyperesponsibleforglycopeptideresis-
tant strains, we used a multiplex PCR (mPCR) as previously
described [25]. During the mPCR, the DNA fragments
were identiﬁed according to their size. This mPCR allowedInternational Journal of Microbiology 3
Table 1: Frequency of glycopeptide-resistant enterococci (GRE) in relation to the number of clinical samples.
Source Specimen Absolute number of GRE isolates Relative frequency (%)
Hospital surveillance Rectal swabs 103 74.7
Hospital clinical samples (n = 35)
Urine 12 8.8
Pus 6 4.4
Peritoneal ﬂuid 4 2.9
Blood 3 2.2
Drainage tube 2 1.4
Bile 2 1.4
Urethral swab 1 0.7
Vaginal swab 1 0.7
Abscess 1 0.7
Catheter 1 0.7
Pyosalpinx 1 0.7
Sputum 1 0.7
Total 138 100.0
Table 2: Oligonucleotide primers used to amplify van genes.
Ampliﬁed gene Oligonucleotide sequence (5  → 3 ) Position PCR product size (bp)
van A A1-5 -GGG-AAA-ACG-ACA-ATT-GC-3  175–191 732
A2-5 -GTA-CAA-TGC-GGC-CGT-TA-3  907–891
van B B1-5 -ATG-GGA-AGC-CGA-TAG-TC-3  173–189 635
B2-5 -GAT-TTC-GTT-CTT-CGA-CC-3  807–791
van C-1 C1-5 -GGT-ATC-AAG-GAA-ACC-TC-3  246–272 822
C2-5 -CTT-CCG-CCA-TCA-TAG-CT-3  1067–1051
van C-2, van C-3 D1-5 -CTC-CTA-CGA-TTC-TCT-TG-3  455–486 439
D2-5 -CGA-GCA-AGA-CCT-TTA-AG-3  885–869
the simultaneous detection of glycopeptide resistance geno-
types: van A, van B, van C1, and van C2/3 (Table 2).
PCR was performed on a DNA thermal cycler (model MJ,
MINI Gradient, BioRad, France) in a ﬁnal volume of 50μL
containing 25μL GoTaq Green Master Mix (Promega, USA),
20pmol of each oligonucleotide primer pair, and 1μLo f
DNA as template. The cycling conditions were 94
◦Cf o r2
minutes followed by 30 cycles of 94
◦Cf o r1m i n u t e ,5 4
◦C
for 1 minute, 72
◦Cf o r1m i n u t e ,a n dt h e n7 2
◦Cf o r1 0
minutes. PCR products were resolved by electrophoresis on
a 1% agarose-Tris-EDTA gel containing 0.5μgp e rm Lo f
ethidium bromide. Smartladder (Eurogentec, Belgium) was
used as molecular weight marker.
After the PCR test, the PCR products obtained were
hybridized with membrane strips coated with E. faecium,
E. faecalis, E. gallinarum, and E. casseliﬂavus species using
the speciﬁc probes provided with the Genotype Enterococcus
kit (Hain Lifescience GmbH, Germany). The hybridization
procedures were performed according to the manufacturer’s
recommendations. This technique was used to conﬁrm
combined identiﬁcation of enterococcal species and van
resistance genes.
2.6. Detection of Genes Encoding GRE Virulence Factors by
Multiplex PCR. The presence of ﬁve genes encoding viru-
lence factors in GRE isolates [14, 22, 26]w e r ei n v e s t i g a t e d
by multiplex PCR using the oligonucleotide primer pairs
previously reported [10]( Table 3), for which primers were
designed based on published DNA sequences from the
GenBank database. The choice of these ﬁve genes was based,
for which they constitute the principal virulence factor genes
reported for E. faecalis and E. faecium strains, on the high
f r e q u e n c yr e p o r t e di nE u r o p e[ 3] and in France [27]i n
enterococci strains, and on their use in mPCR schemes [13].
PCR was performed as described above. Each 50μLP C R
mixtureconsistedof25μLGotaqGreenMasterMix,20pmol
of each oligonucleotide primer pair for asa1, gel E, hyl, cyl
A, and esp,a n d5 μL of DNA as template. Ampliﬁcations
were performed under the following conditions: 95
◦Cf o r1 5
minutes, followed by 30 cycles of 1 minute at 94
◦C, 1 minute
at 56
◦C, 1 minute at 72
◦C, and then 10 minutes at 72
◦Cf o r
the last cycle. PCR products were then sequenced.
2.7. PFGE. Macrorestriction analysis by PFGE was per-
formed for 131 E. faecium and 7 E. faecalis isolates with
SmaI-restricted whole-cell DNA embedded in 1% agarose
plugs and separated in a 1.2% pulsed-certiﬁed agarose gel
with a contour-clamped Homogeneous Electric Field (CHEF
DRII apparatus; BioRad, France). E. faecium Van A CIP
104676 and E. faecalis Van B CIP 104105 strains were used
as reference strains. Concatemers of bacteriophage λ-ladder
were used as molecular weight marker (BioRad, France).4 International Journal of Microbiology
Table 3: Oligonucleotide primers used to amplify virulence factor genes.
Gene Virulence factor Primer name Oligonucleotide sequence (5  to 3 ) Product
size (bp)
asa1 Aggregation substance, encoded by the
plasmid asa1
ASA 11 GCA-CGC-TAT-TAC- GAA -CTA-TGA 375
ASA 12 TAA-GAA-AGA-ACA-TCA-CCA-CGA
gelE Gelatinase, encoded by the chromosomal
gelE
GEL 11 TAT-GAC-AAT-GCT-TTT-TGG-GAT 213
GEL 12 AGA-TGC-ACC-CGA-AAT-AAT-ATA
cylA Cytolysin, encoded by the plasmid cylA CYT I ACT-CGG-GGA-TTG-ATA-GGC 688
CYT II GCT-GCT-AAA-GCT-GCG-CTT
esp Enterococcal surface protein, encoded by
the chromosomal esp
ESP 14F AGA-TTT-CAT-CTT-TGA-TTC-TTG-G 510
ESP 12R AAT-TGA-TTC-TTT-AGC-ATC-TGG
hyl Hyaluronidase, encoded by the
chromosomal hyl
HYL n1 ACA-GAA-GAG-CTG-CAG-GAA-ATG 276
HYL n2 GAC-TGA-CGT-CCA-AGT-TTC-CAA
Table 4: Ampliﬁcation and sequencing primers for ddl, gyd, gdh, and psts.
Gene Primer name Oligonucleotide sequence (5  to 3 )P r o d u c t s i z e ( b p )
ddl DDL1 GAG-ACA-TTG-AAT-ATG-CCT-TAT-G 465
DDL2 AAA-AAG-AAA-TCG-CAC-CG
gdh GDH1 GGC-GCA-CTA-AAA-GAT-ATG-GT 530
GDH2 CCA-AGA-TTG-GGC-AAC-TTC-GTC-CCA
gyd GYD1 CAA-ACT-GCT-TAG-CTC-CAA-GGC 556
GYD2 CAT-TTC-GTT-GTC-ATA-CCA-AGC
psts PSTS1 TTG-AGC-CAA-GTC-GAA-GCT-GGA 583
PSTS2 CGT-GAT-CAC-GTT-CTA-CTT-CC
ddl: D-alanine-D-alanine ligase, gdh: glucose-6-phosphate dehydrogenase, gyd:glyceraldehyde-3-phosphate dehydrogenase, and psts: phosphate ATP-binding
cassette transporter.
PFGE patterns were interpreted according to the criteria
of Tenover et al. [28]. The similarity dendrogram was
constructed with the unweighted pair-group method with
arithmetic means (UPGMA) using the DICE correlation
coeﬃcient.
2.8. MLST Sequence Types. Four housekeeping genes (loci)
(Table 4)w e r ea m p l i ﬁ e df o re a c hi s o l a t e[ 29]. The choice
of these housekeeping genes was based on their putative
function and on their use in MLST schemes of E. faecium.
Information on these loci is available at the MLST web site
(http://efaecium-mslt.net).
2.9. PCR. Internal 400- to 600-bp gene fragments were
ampliﬁed by PCR. Reactions were performed in 50μLv o l -
umes composed of 25μL GoTaq Green Master Mix, 20 pmol
of each oligonucleotide primer pair, and 1μLo fb a c t e r i a l
DNA as template. PCR conditions for all ampliﬁcation
r e a c t i o n sw e r ea sf o l l o w s :9 4
◦C for 3 minutes, 35 cycles
at 94
◦C for 30 seconds, 50
◦C for 30 seconds, 72
◦Cf o r
30 seconds, and 72
◦C for 5 minutes The amplicons were
analyzed by electrophoresis as described above.
2.10. MLST Data Analysis. Sequences of each allele were
trimmedandcomparedwithallallelesintheMLSTdatabase.
Each unique nucleotide sequence was assigned a unique
allele number. The allele proﬁle for each isolate was deter-
mined and consisted of a line listing of allele numbers for
each gene. Isolates were then assigned a sequence type (ST)
according to their allelic proﬁles.
2.11. Nucleotide Sequence Accession Numbers. The sequences
of van genes, virulence factor genes, and the alleles house-
keeping genes have been given the following GenBank
accession numbers: HM641733 (van A), HM 641734 (asa1),
HM 641735 (gel E), HM 641736 (psts), HM 641737 (gdh),
and HM 641738 (gyd)f o rE. faecalis; HM 641739 (van A),
HM 641740 (hyl), HM 641741 (esp), HM 641742 (psts), HM
641743 (gdh), HM 641744 (gyd), and HM 641745 (esp)f o rE.
faecium.
3. Results
3.1. Epidemiology. GRE was isolated from a total of 127
patients hospitalized during the period from April 2004
through January 2009. The ﬁrst GRE isolates observed were
two E. faecalis strains isolated from urinary tract infection of
patients hospitalized in the AUH nephrology and orthopedic
wards (April and May 2004, resp.). From 2005 to 2008, ﬁve
other GREfs were isolated (three from rectal swabs and two
from vaginal swab and pus) from patients hospitalized in
AUH wards.International Journal of Microbiology 5
From July to November 2005, during an outbreak
comprising a limited number of cases, 33 GREfm (23
from rectal swabs and 10 from peritoneal ﬂuid, blood,
drainage tube, pus, bile, and catheter) were obtained from 25
colonized/infected patients, also hospitalized in AUH wards.
The major outbreak occurred from May 2006 to January
2009. Ninety-eight GREfm (22 isolates from clinical samples
and 76 isolates from screening rectal swabs) were obtained
from 95 patients hospitalized at AUH (85 patients), PPH
(6 patients), MH (2 patients), DH (1 patient), and SQH
(1 patient). The most recent isolates were obtained during
fecal screening of all hospitalized contact patients, as part of
infection control measures.
3.2. Patients Carrying GRE Isolates. Of 127 hospitalized
patients included in this study, 67 (52.7%) were men and
60 (47.3%) were women. The mean age of these patients
was 70.1 years (range: 19–98 years) in men and 73.6 years
(range: 16–95 years) in women (M/F sex ratio: 1 : 12).
These patients were classiﬁed as either colonized, 74.8%
(95/127), or infected, 25.2% (32/127), according to the
deﬁnitions of French guidelines [30] based on those of
the Centers for Disease Control and Prevention [31]. This
distribution conﬁrms the low ratio of infections versus
colonization. The patient distribution according to GRE-
positive specimens showed that 94 patients had one GRE-
positive surveillance rectal swab and 1 patient had 3 GRE-
positive surveillance rectal swabs; twenty-four patients had
one GRE-positive clinical sample, and 8 patients had 11
GRE-positive clinical samples plus 6 GRE-positive surveil-
lance rectal swabs. Application of infection control measures
included weekly surveillance cultures and environmental
decontamination guided by culture and PCR-hybridization
results.
3.3. PCR Assays and Sequencing Results. Sequencing yielded
ﬁve distinct DNA sequences: one from Van A PCR (732bp),
one from Esp (510bp), one from Asa 1 (375bp), one
from Hyl (276bp), and one from Gel E (213bp). The
nucleotide and amino acid sequences of van gene and
virulence factor genes obtained were compared to the
known sequences of Genbank. The nucleotide and amino
acid sequences of the van A gene had 100% genetic
identity and 100% amino acid identity with E. faecium
pIP816 plasmid, accession n◦AM932524. The esp gene
sequences exhibited a 100% nucleotide and amino acid
homology with sequences for E. faecium isolate E470
putative enterococcal surface protein (esp) gene, accession
n◦AY322500. The nucleotide and amino acid sequences
of asa1 gene from our E. faecalis strains were identical
to those known of E. faecalis plasmid pAD1 asa1 gene
for aggregation substance (100% genetic and amino acid
identity), accession n◦X17214. The Hyl sequences showed
best similarity with E. faecium putative hyaluronidase (hyl)
gene (100% genetic identity; 100% amino acid identity),
accession n◦AF544400, while the partial Gel E sequences
showed best similarity with E. faecalis gelatinase (gel E)g e n e
(100%geneticidentity;100%aminoacididentity),accession
n◦M37185.
3.4. Molecular Identiﬁcation, Antibiotic Susceptibility, and
Virulence Factors. The molecular identiﬁcation of 138 GRE
showed that 131 enterococci isolates belonged to the E. fae-
ciumspecies (94.9%) and 7 (5.1%) belonged to the E. faecalis
species. The van A gene was the only glycopeptide resistance
determinant found in all isolates studied. The resistance
patternsfortheisolatesareshowninTable 5.The131GREfm
isolateswereresistanttopenicillin(MICs,96to>256μg/mL)
and ampicillin (MICs, 48 to >256μg/mL). One hundred
twenty-eight of these isolates showed HLKR [(high-level
kanamycin resistance) (MICs, >256 to >512μg/mL)], 116
showed HLGR [(high-level gentamicin resistance) (MICs,
>256 to >512μg/mL)], and 53 showed HLSR [(high-level
streptomycin resistance) (MICs, >256 to >512μg/mL)].
The 7 GREfs were susceptible to penicillin (MICs, 1.5–
4μg/mL)andampicillin(MICs,0.50–1.5μg/mL).Sixisolates
showed HLKR (MICs of >512μg/mL) and HLGR (MICs,
>256 to >512μg/mL), and one isolate showed HLSR (MIC,
>512μg/mL). Glycopeptide susceptibility test results were
in agreement with resistance genotypes: the MICs of van-
comycinwere>256μg/mL,andtheMICsofteicoplaninwere
32 to >256μg/mL. Genes coding for Hyl and Hyl+ Esp were
detected in 39 (29.8%) and 92 (70.2%) of the 131 GREfm
isolates, respectively. Three of the 7 GREfs were positive for
gel E+ asa 1 genes, 3 were positive for gel E gene, and 1 was
positive for asa 1 gene (Table 5). The cyl A gene was not
detected in any of the GRE isolates examined.
3.5. Molecular Typing and Clonal Characteristics of GRE.
Analysis of PFGE proﬁles showed that 131 GREfm isolates
shared a similar electrophoretic proﬁle, designated type A,
and were clonally related. This PFGE type A encompassed
26 diﬀerent subtypes (A1–A26). Subtypes A16 and A26 each
corresponded to two isolates. The other subtypes corre-
sponded to single isolate. The seven GREfs isolates appeared
to be more heterogeneous on the basis of their PFGE proﬁles
in six diﬀerent types (B–G). Only type G was identiﬁed in
two isolates with identical proﬁles. These two isolates were
obtained from two diﬀerent patients hospitalized in diﬀerent
wards. These pulsotypes were considered to be sporadic
proﬁles [32].
3.6. Diversity of Housekeeping Genes. MLST PCR was per-
formed for all 138 isolates belonging to PFGE types A–
G, but only 18 PCR products were sequenced. These 18
PCR products were selected as being representative of all
anatomical sites of sampled patients and all hospital clinical
wards during the study period. Twelve GREfm isolates were
selected because they shared the same PFGE type A and
subtypes (A1, A3, A5–A7, A10, A15, A16, A20, and A26) and
were isolated at various times over the study period. The six
GREfs isolates were chosen because of their diﬀerent PFGE
proﬁles (B–G) showing a diﬀerence of at least six bands from
PFGE pattern A [33].
The restriction proﬁles of GREfm strains, presented
in the dendrogram (Figure 1), show that the 12 selected
pulsotype A strains belong to subtypes A1, A3, A5–A7,
A10, A15, A16, A20 and A26. These subtypes correspond
to 3 clones. The clone 2 included 7 strains belonging to6 International Journal of Microbiology
Table 5: Characteristics of glycopeptide-resistant isolates.
Isolate type Phenotype Van Susceptibility data (MIC-μg/mL) PFGE type Virulence factors
Penicillin Ampicillin Vancomycin Teicoplanin
A3 1 . 5 >256 32 B Gel E+ Asa1+
GRE faecalis n = 7A 3 1 . 5 >256 32 C Gel E+ Asa1+
A 3 0.50 >256 32 D Gel E+
A 3 0.75 >256 32 E Gel E+
A1 . 5 1 . 5 >256 >256 F Gel E+
A2 1 . 5 >256 32 G Asa1+
A4 1 >256 32 G Gel E+ Asa 1+
GRE faecium 39 (29.8%) A 96 to >256 48 to >256 >256 32 to >256 A Hyl+
n = 131 92 (70.2%) A 96 to >256 48 to >256 >256 32 to >256 A Hyl+ Esp+
Asa1: Aggregation substance; gel E: Gelatinase, cylA: Cytolysin; esp: Enterococcal surface protein; hyl: Hyaluronidase.
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Figure 1: PFGE dendrogram with the corresponding MLST sequence types of the GRE isolates, digested with SmaI. Strains were clustered
by the unweighted pair-group method with arithmetic mean (UPGMA). Each row represents a unique PFGE type with its unique PFGE
pattern. The corresponding MLST sequence type (ST) is shown with the corresponding strains. Molecular weight: (MW). Bacteriophage
λ-ladder is given in kbp (48.5kb–485.0kb) ∗PFGE type A (PA) isolates 3, 4, 6–8, 10–13–24, 27, 29–32, 34, 36, 37, 39–43, 45, 46, 49–53,
55–60, 63–101, 103–115, 117–138. (+): positive.
subtypes A1, A3, A5, A6, A7, A10, and A15. The percentage
of similarity between each strain was between 90% and
98%. The 3 strains of clone 4 belong to subtypes A16
and A20 and present the percentage of similarity between
78% and 91%. Finally, the 2 strains of clone 6 belong to
subtype A26 and have a percentage of similarity of 90%.
In total, the 12 subtypes A presenting a percentage of
similarity between 78% and 98% show the propagation of
one GREfm clone in hospitals of the Picardy region. The
6 GREfs pulsotypes analysis allowed to identify 4 clones.
Clone 1 included 3 strains which present a percentage
of similarity between 70% and 86%, two of these strains
belonging to pulsotype G have 86% of homology and the
remaining one strain belonging to pulsotype B has 70%
of homology. The strains of clones 3,5, and 7 belonging
to pulsotypes C, D, and F have 72%, 67%, and 57% of
homology, respectively. These strains were isolated from
patients hospitalized at nephrology, orthopedic surgery,
thoracic surgery, and endocrinology wards and two patients
from hepatology and gastroenterology wards. The dendro-
gram (Figure 1) may let us fear the emergence of other
ERGfs clones as well as the dispersion of these bacteria
following an epidemic mode, as seems to be the case of
clone 1.
MLSTanalysisofthe18isolatesrevealed9STs(Figure 1).
The sequence types most frequently identiﬁed were ST6
(7 isolates) and ST7 (4 isolates) which shared the four
housekeeping alleles, while ST1 (1 isolate), ST2 (1 isolate),
ST3 (1 isolate), ST4 (1 isolate), ST5 (1 isolate), and ST8
(1 isolate) shared three of the four housekeeping alleles.
The majority of these isolates belonged to the E. faecium
species. They were clustered together with PFGE and were,
therefore, considered to belong to the same pulsotype A.
They were involved in a sustained outbreak in the hospitals
of the Picardy region. Of six E. faecalis isolates, ﬁve were
genotypically diﬀerent and corresponded to 3 diﬀerent STs
(ST5, ST6, and ST9) (Figure 1). These STs diﬀered from each
other at one or four loci.International Journal of Microbiology 7
4. Discussion
GRE are distributed worldwide, but their epidemiology
appears to vary on a regional basis. Thus, polyclonal isolates
were described [34], whereas some European Centres have
reported nosocomial outbreak of GRE associated with very
diverse epidemiological situations [3]. The data presented in
this study show that most of the hospital-derived GREfm are
part of a single clonal (pulsotype A). Among the acquired
genesconferringresistancetoglycopeptides,vanAistheonly
identiﬁed determinant. The use of multiplex PCR allowed
simultaneous detection of enterococcal genes that encode for
aggregation substance (asa 1), gelatinase (gel E), cytolysin
(cylA),enterococcalsurfaceprotein(esp),andhyaluronidase
(hyl). In 131 GREfm isolates, the asa 1 and gel E genes were
not detected in this study which is in agreement with the
results reported by other investigators [13, 35]. In contrast,
these genes were found in GREfs.
The combined presence of hyl and esp genes was found in
70.2% of 131 GREfm isolates tested, which is in accordance
with the ﬁndings of Vankerckhoven et al. [13]a n dR i c ee t
al. [22]. In contrast, the only esp gene was not detected,
as described elsewhere [13, 36]. The hyl gene was found in
29.8% of the 131 GREfm isolates, which is in contrast with
the ﬁndings of Vankerckhoven et al. [13], who detected hyl
gene in only 17% of the E. faecium isolates collected.
PFGE has been proposed as the method of choice
from epidemiological typing of GREfm [37], although
alternative technique, such as MLST analysis, has also been
used successfully for characterization of GRE isolates [33].
The ﬁndings obtained by PFGE regarding the clonality of
GREfm isolates were in accordance with MLST typing.
A subpopulation of E. faecium adapted to the hospital
setting, and consisting of strains responsible for epidemics,
was characterized. The 12 representative GREfm isolates
of pulsotype A analyzed by MLST belonged to ST1–ST4,
ST6–ST8. These isolates are characterized by the presence
of Hyl and Esp virulence factors as GREfm markers and
high-level resistance to penicillin, ampicillin, vancomycin,
and teicoplanin, in accordance with data of the literature
[38, 39]. Top et al. [40] showed that their epidemic strains
belonging to certain STs have been grouped in clonal
complex 17 (CC17) of E. faecium. CC17 was deﬁned upon
MLST and is characterized by resistance to quinolones and
ampicillin and the presence of the enterococcal surface
protein (Esp) in the majority of isolates. The Hyl and Esp
virulence factors have also been detected in vancomycin-
susceptible strains [10]. The hypothesis proposed to explain
the widespread distribution is the emergence of epidemic
strains adapted to the hospital setting, which acquired
vancomycin resistance determinants by horizontal gene
transfer.
In this study, PFGE demonstrated the existence of a
GREfm epidemic clone within the E. faecium population.
The allelic proﬁles of this clone are relatively homogeneous,
which suggests that they are genetically related. The GREfs
isolates investigated by MLST were grouped into six diﬀerent
PFGE genogroups. This genetic diversity may not have
emerged in the E. faecium epidemic population.
In conclusion, our data indicate that GREfm van A
strains remain predominant in our region among GRE iso-
lates,unlikethatofthenextNorthregionofFrance,wherean
E. faecium vanB outbreak has been reported [6]. The recent
increase in the number of GREfm in hospitals of the Picardy
region might be due to the appearance and spread of a
hospital-adapted, multidrug-resistant GREfm clone belong-
ing to an internationally disseminated lineage. Horizontal
gene transfer and clonal spread may both have contributed
to the high rate of GREfm colonizations/infections. The
divisions of colonized/infected patients into sectors, and an
increased surveillance during the rehospitalizations of these
patients, allow for the circumscription of the epidemic.
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